LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

Home・Aandelen Lijst・Celsion Corp

Celsion Corp

Gesloten

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

Max

Belangrijke statistieken
By Trading Economics
Werknemers	25

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+736.12% upside

Marktinformatie
By TradingEconomics
Marktkapitalisatie	938K
Vorige openingsprijs	0
Vorige sluitingsprijs	0

Celsion Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

15 mrt 2026, 21:14 UTC

Belangrijke Nieuwsgebeurtenissen

Week Ahead for FX, Bonds: Central Bank Decisions -2-

15 mrt 2026, 21:14 UTC

Belangrijke Nieuwsgebeurtenissen

Week Ahead for FX, Bonds: Central Bank Decisions in Focus After Jump in Energy Prices

16 mrt 2026, 00:00 UTC

Belangrijke Nieuwsgebeurtenissen

Hack on U.S. Medical Company Shows Reach of Iran's Cyber Capabilities -- WSJ

15 mrt 2026, 23:45 UTC

Marktinformatie

Nikkei May Decline on Concerns About Prolonged Middle East Conflict -- Market Talk

15 mrt 2026, 23:44 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Gold Falls as Rising Energy Prices Exacerbate Inflation Worries -- Market Talk

15 mrt 2026, 23:35 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Oil Futures Rise on Supply Disruption Concerns -- Market Talk

15 mrt 2026, 23:00 UTC

Acquisities, Fusies, Overnames

Micron Completes Acquisition Of PSMC's Tongluo P5 Site In Taiwan >MU

15 mrt 2026, 22:37 UTC

Marktinformatie

March Rate Hike Would Distance RBA From Government's May Budget -- Market Talk

15 mrt 2026, 22:18 UTC

Marktinformatie

RBA's Likely Hike Motivated By Inflation, Not Middle East -- Market Talk

15 mrt 2026, 22:14 UTC

Winsten

Genscript Biotech 2025 Adj Net $230.35M Vs. Adj Net $59.83M>1548.HK

15 mrt 2026, 22:14 UTC

Winsten

Genscript Biotech: 2025 Loss Due to High Base Effect, One-off Unrealized Gains Seen Last Year >1548.HK

15 mrt 2026, 22:14 UTC

Winsten

Genscript Biotech 2025 Rev $959.53M Vs. $594.49M >1548.HK

15 mrt 2026, 22:14 UTC

Winsten

Genscript Biotech 2025 Loss $532.83M Vs. Net $2.96B >1548.HK

15 mrt 2026, 22:14 UTC

Winsten

Genscript Biotech: 2025 Rev Supported by Substantial Increase in License Revenue>1548.HK

15 mrt 2026, 22:00 UTC

Belangrijke Nieuwsgebeurtenissen

Oil Industry Warns Trump Administration Energy Crisis Will Likely Worsen -- WSJ

15 mrt 2026, 22:00 UTC

Belangrijke Nieuwsgebeurtenissen

Oil Industry Warns Trump Administration Energy Crisis Will Likely Worsen -- WSJ

15 mrt 2026, 03:00 UTC

Belangrijke Nieuwsgebeurtenissen

For Xi, Iran War Reinforces View of U.S. as Dangerous Superpower -- WSJ

14 mrt 2026, 15:00 UTC

Belangrijke Nieuwsgebeurtenissen

Iran War Delivers Windfall to America's Oil Country -- WSJ

14 mrt 2026, 02:03 UTC

Winsten

This Copper Stock Is Worth Mining for Profits -- Barrons.com

14 mrt 2026, 01:32 UTC

Acquisities, Fusies, Overnames

Bill Ackman's Pershing Square IPO Is Back On -- Barrons.com

14 mrt 2026, 00:29 UTC

Acquisities, Fusies, Overnames

13D Filings -- Barrons.com

13 mrt 2026, 22:27 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Bahrain Faces Uncertainty But Has Support Amid War, S&P Says -- Market Talk

13 mrt 2026, 22:13 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Saudi Arabia Seen as Able to Weather Iran Conflict, S&P Says -- Market Talk

13 mrt 2026, 22:04 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Emirate of RAK Outlook Stable Despite Iran War, S&P Says -- Market Talk

13 mrt 2026, 22:00 UTC

Acquisities, Fusies, Overnames

Trump Administration Set to Receive $10 Billion Fee for Brokering TikTok Deal -- WSJ

13 mrt 2026, 20:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

13 mrt 2026, 20:50 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Financial Services Roundup: Market Talk

13 mrt 2026, 20:02 UTC

Marktinformatie

Canada Rate Hike in 2026 Would Mark 'Extraordinarily Bad' Policy -- Market Talk

13 mrt 2026, 19:50 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Oil Posts Weekly Gains As Middle East Conflict Drags On -- Market Talk

13 mrt 2026, 19:35 UTC

Belangrijke Nieuwsgebeurtenissen

Oil Prices Hover Near $100. India Asks Iran to Allow 23 Tankers Through Strait of Hormuz. -- Barrons.com

Peer Vergelijking

Prijswijziging

Celsion Corp Prognose

Koersdoel

By TipRanks

736.12% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 25 USD 736.12%

Hoogste 25 USD

Laagste 25 USD

Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor Celsion Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

1 ratings

Buy

Hold

Sell

Gebaseerd op 1 analisten die aandelenratings hebben gegeven aan Celsion Corp - Dist in de afgelopen 3 maanden.

Financieel

Over Celsion Corp

Imunon, Inc., a clinical-stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. The company's lead clinical program IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development. Its preclinical stage products include IMNN-101, a COVID-19 booster vaccine; IMNN-102 for the treatment of Lassa virus; and IMNN-201, a Trp2 tumor associated antigen cancer vaccine in melanoma. In addition, the company develops non-viral DNA technology across four modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; PlaCCine for the coding of viral antigens that can elicit a strong immunological response; FixPlas for the application of Imunon's DNA technology to produce universal cancer vaccines; and IndiPlas, which is in the discovery phase for the development of personalized cancer vaccines or neoepitope cancer vaccines. Imunon, Inc. was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. The company was founded in 1982 and is headquartered in Lawrenceville, New Jersey.